09/04/18 Bridge Therapeutics Team to Speak on Tackling a Key Source of the Opioid Crisis
Dr. Greg Sullivan, Chief Scientific Officer, Dr. Dave Bergstrom. Chief Operations Officer, and Tim Peara of will be speaking about how Bridge Therapeutics’ lead investigational drug could be a key part of ending the opioid crisis.
September 4, 2018
Each year 70 million Americans will take an opioid for pain. Of these, 17 million take a strong opioid daily. It is these 17 million patients who are most at risk of addiction disorders leasing to shattered relationships, overdoes, and possibly death. 70% of opioid overdose victims started by abusing pain medication. A key part to ending the Opioid Crisis will be providing a safer therapy than opioids for chronic pain.